Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
13 January 2022 - 8:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of January 2022
Commission File Number: 001-39997
Adagene Inc.
(Exact Name of Registrant as Specified in Its Charter)
4F, Building C14, No. 218
Xinghu Street, Suzhou Industrial Park
Suzhou, Jiangsu Province, 215123
People’s Republic of China
+86-512-8777-3632
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F
x Form 40-F
o
Indicate by
check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by
check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
Explanatory Note
Senior management of Adagene Inc. (the “Company”) plan to present the information in the presentation slides
attached hereto as Exhibit 99.1 at various investor and analyst meetings scheduled during the week of January 12, 2021 and from time to
time.
The furnishing of the attached presentation is not an admission as to the materiality of any information therein. The information
contained in the presentation is summary information that is intended to be considered in the context of more complete information included
in the Company’s filings with the Securities and Exchange Commission (the “SEC”) and other public announcements that
the Company has made and may make from time to time. The Company undertakes no duty or obligation to update or revise the information
contained in this report, although it may do so from time to time as its management believes is appropriate. Any such updating may be
made through the filing or furnishing of other reports or documents with the SEC or through other public disclosures.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
Adagene Inc.
|
|
|
|
|
|
|
By:
|
/s/ Peter (Peizhi) Luo
|
|
|
Name: Peter (Peizhi) Luo
|
|
|
Title: Chief Executive Officer
|
|
|
|
|
Date: January 12, 2022
|
|
EXHIBIT INDEX
Adagene (NASDAQ:ADAG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Adagene (NASDAQ:ADAG)
Historical Stock Chart
From Apr 2023 to Apr 2024
